Jonathan Finlay, MB, ChB, FRCP

The Evolution of Precision Medicine for Children With Aggressive Brain Tumors

The Head Start 4 clinical trial introduces risk stratification and builds on the success of bone marrow transplantation for young children with malignant embryonal tumors.
September 26, 2017  |  Written by
,